Connection

Daniel Wrapp to Respiratory Syncytial Virus Vaccines

Back to Details
This is a "connection" page, showing publications Daniel Wrapp has written about Respiratory Syncytial Virus Vaccines.
Daniel Wrapp
Connection Strength
0.195
Respiratory Syncytial Virus Vaccines
  1. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017 05 03; 9(388).
    View in: PubMed
    Score: 0.155
  2. Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. 2018 02 20; 48(2):339-349.e5.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.